<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>chemotherapy Archives - Iran News Daily</title>
	<atom:link href="https://irannewsdaily.com/tag/chemotherapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://irannewsdaily.com/tag/chemotherapy/</link>
	<description></description>
	<lastBuildDate>Mon, 07 Oct 2019 07:17:11 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.6.4</generator>

<image>
	<url>https://irannewsdaily.com/wp-content/uploads/2020/04/cropped-iranlogo-32x32.png</url>
	<title>chemotherapy Archives - Iran News Daily</title>
	<link>https://irannewsdaily.com/tag/chemotherapy/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Cancer patients exercising have less heart damage of chemotherapy</title>
		<link>https://irannewsdaily.com/2019/10/cancer-patients-exercising-have-less-heart-damage-of-chemotherapy/</link>
					<comments>https://irannewsdaily.com/2019/10/cancer-patients-exercising-have-less-heart-damage-of-chemotherapy/#respond</comments>
		
		<dc:creator><![CDATA[reporter 1222]]></dc:creator>
		<pubDate>Mon, 07 Oct 2019 09:30:19 +0000</pubDate>
				<category><![CDATA[Society]]></category>
		<category><![CDATA[Cancer Treatment]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<guid isPermaLink="false">https://irannewsdaily.com/?p=100021</guid>

					<description><![CDATA[<p>Patients with cancer should receive a tailored exercise prescription to protect their heart, reported a paper published in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC). “Cancer patients are often less active than adults without cancer,&#8217; said author Dr. Flavio D&#8217;Ascenzi, University of Siena, Italy. A a result [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2019/10/cancer-patients-exercising-have-less-heart-damage-of-chemotherapy/">Cancer patients exercising have less heart damage of chemotherapy</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div>
<h3 class="lide">Patients with cancer should receive a tailored exercise prescription to protect their heart, reported a paper published in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC).</h3>
</div>
<div class="itemcontent">
<p>“Cancer patients are often less active than adults without cancer,&#8217; said author Dr. Flavio D&#8217;Ascenzi, University of Siena, Italy. A a result of not doing any exercise, cancer patients are more vulnerable to heart damage of chemotherapy.</p>
<p>“However, exercise is essential for patients diagnosed with cancer who are under treatment, irrespective of the type of treatment,<a href="https://irannewsdaily.com/" target="_blank" rel="noopener noreferrer"> Iran News</a> quotes what eurekalert reported..</p>
<p>“Endurance training is more effective for improving cardiovascular performance and reducing inflammation, but resistance training may be a better starting point for frail cancer patients,” he continued.</p>
<p>“Other types of exercise, such as inspiratory muscle training, are safe and effective, particularly in those with thoracic cancer; therefore, the specific exercise should be chosen based on individual characteristics.”</p>
<p>Cardiovascular diseases are common side effects in patients with cancer. This is the result of cardiotoxicity, whereby cancer treatment impairs heart function and structure, or accelerated development of cardiovascular disease, especially when risk factors such as high blood pressure are present. Furthermore, cardiovascular diseases and cancer often share the same risk factors. Therefore, cancer patients are advised to eat healthily, quit smoking, control their weight, and exercise.</p>
<p>The paper highlights the importance of an individual exercise plan for each patient, taking into account personal history, cancer treatment, response to exercise, and personal preferences. Exercise should start as soon as possible, even before starting treatment to reduce damage of chemotherapy.</p>
<p>A multidisciplinary team should be involved in formulating an exercise prescription, including oncologists, cardiologists, physical therapists, nurses, nutritionists, and psychologists. Cardiac evaluation, with exercise testing (and particularly cardiopulmonary exercise testing or lactate testing) to determine response to exercise, is the starting point. The appropriate &#8216;dose&#8217; of exercise (as usually done for a drug) can then be prescribed, including the intensity, type of training, and training volume (hours/minutes of training per week).</p>
<p>“Defining the intensity and volume of exercise is important for maximizing the benefits of physical activity while avoiding muscular soreness, fatigue, and sleep disorders,&#8217; said D&#8217;Ascenzi.</p>
<p>Ongoing treatment is not a contraindication to exercise, but patients are urged to consult their doctor before starting a new activity. Specific guidance is provided: For example, patients with low hemoglobin levels should avoid high intensity activities; those with low platelet levels (needed for blood clotting) should not do contact sports. Activities that could increase the risk of fracture should be avoided in frail patients. Breathlessness or fatigue must be investigated but, after excluding associated health problems, exercise can help cope with fatigue, which is relatively common in cancer patients.</p>
<p>D&#8217;Ascenzi concluded: “Physical activity before, during and after cancer treatment can counteract the negative effects of therapies on the cardiovascular system. In addition, it can relieve symptoms such as nausea and fatigue and help prevent unwanted changes in body weight.”</p>
</div>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2019/10/cancer-patients-exercising-have-less-heart-damage-of-chemotherapy/">Cancer patients exercising have less heart damage of chemotherapy</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://irannewsdaily.com/2019/10/cancer-patients-exercising-have-less-heart-damage-of-chemotherapy/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Iranian researchers achieve formula of anti-cancer drug</title>
		<link>https://irannewsdaily.com/2019/01/iranian-researchers-achieve-formula-of-anti-cancer-drug/</link>
					<comments>https://irannewsdaily.com/2019/01/iranian-researchers-achieve-formula-of-anti-cancer-drug/#respond</comments>
		
		<dc:creator><![CDATA[reporter 1222]]></dc:creator>
		<pubDate>Sun, 06 Jan 2019 08:00:18 +0000</pubDate>
				<category><![CDATA[technology]]></category>
		<category><![CDATA[anti-cancer drug]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[local production]]></category>
		<category><![CDATA[medicine]]></category>
		<guid isPermaLink="false">https://irannewsdaily.com/?p=46411</guid>

					<description><![CDATA[<p> Iranian researchers at Urmia University gained the technical knowledge to produce the anti-cancer drug, Busulfan.  Busulfan, also known by its brand names Myleran or Busilvex, is a chemotherapy drug used before a stem cell transplant to treat blood cancers. It may also be used to treat other blood-related disorders and cancers. “The drug is majorly [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2019/01/iranian-researchers-achieve-formula-of-anti-cancer-drug/">Iranian researchers achieve formula of anti-cancer drug</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p class="summary"><strong> Iranian researchers at Urmia University gained the technical knowledge to produce the anti-cancer drug, Busulfan. </strong></p>
<p>Busulfan, also known by its brand names Myleran or Busilvex, is a chemotherapy drug used before a stem cell transplant to treat blood cancers. It may also be used to treat other blood-related disorders and cancers.</p>
<p>“The drug is majorly supplied only by USA and France. Currently, it is imported into the country and is quite expensive and hard to get,” ISNA quoted the research director, Dr. Nader Norouzi, as saying on Friday.</p>
<p>According to Norouzi, the Health Ministry had asked the universities and research centers to manufacture 160 vital medicines and Busulfan was one of them, which now can be produced locally and with high purity.</p>
<p>“We expect the Health Ministry to issue the necessary permits so that we can run the necessary laboratory and clinical tests for quality control of the drug and manufacture it in large quantities,” Norouzi added.</p>
<p>“Last year, the drug’s price was set at 6 million rials (about $142) by State Welfare Organization but if we can manufacture it locally, its price will be lowered to around 2 million rials (about $47),” he noted.</p>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2019/01/iranian-researchers-achieve-formula-of-anti-cancer-drug/">Iranian researchers achieve formula of anti-cancer drug</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://irannewsdaily.com/2019/01/iranian-researchers-achieve-formula-of-anti-cancer-drug/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
